RadMD Co-Founder and Principal, Kohkan Shamsi, attended the Clinical Operations in Oncology Trials West Coast this week.
During the event, Shamsi presented a session titled ‘early phase oncology imaging endpoints: optimizing the opportunity and avoiding the risks’.
The Clinical Operations in Oncology Trials West Coast conference provided a platform for industry experts, professionals, and researchers to come together and discuss the latest advancements and challenges in clinical operations within the field of oncology. The event was a valuable opportunity for attendees to exchange knowledge, share best practices, and explore innovative strategies for conducting effective oncology trials.
Shamsi’s presentation received positive feedback from the audience, as he delved into the intricacies of early-phase oncology imaging endpoints. His expertise and insights offered valuable guidance to fellow professionals attending the conference. The session sparked engaging discussions and highlighted the significance of optimizing imaging endpoints in order to enhance the accuracy and efficacy of oncology trials.
The presence of RadMD Co-Founder and Principal, Kohkan Shamsi, at the Clinical Operations in Oncology Trials West Coast conference further solidified the company’s commitment to advancing the field of oncology through innovative research and clinical practices. RadMD continues to be at the forefront of revolutionizing clinical operations in oncology trials, working towards improving patient outcomes and contributing to the overall progress of cancer research.